Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Aug;24(6):898-902.
doi: 10.1016/j.bbi.2010.01.008. Epub 2010 Jan 25.

Plasma cytokine profiles in Fragile X subjects: is there a role for cytokines in the pathogenesis?

Affiliations

Plasma cytokine profiles in Fragile X subjects: is there a role for cytokines in the pathogenesis?

Paul Ashwood et al. Brain Behav Immun. 2010 Aug.

Abstract

Background: Fragile X syndrome (FXS) is a single-gene disorder with a broad spectrum of involvement and a strong association with autism. Altered immune responses have been described in autism and there is potential that in children with FXS and autism, an abnormal immune response may play a role.

Objectives: To delineate specific patterns of cytokine/chemokine profiles in individuals with FXS with and without autism and to compare them with typical developing controls.

Methods: Age matched male subjects were recruited through the M.I.N.D. Institute and included: 19 typically developing controls, 64 subjects with FXS without autism and 40 subjects with FXS and autism. Autism diagnosis was confirmed with ADOS, ADI-R and DSM IV criteria. Plasma was isolated and cytokine and chemokine production was assessed by Luminex multiplex analysis.

Results: Preliminary observations indicate significant differences in plasma protein levels of a number of cytokines, including IL-1alpha, and the chemokines; RANTES and IP-10, between the FXS group and the typical developing controls (p<0.01). In addition, significant differences were observed between the FXS group with autism and the FXS without autism for IL-6, eotaxin, MCP-1 (p<0.04).

Conclusions: In this study, the first of its kind, we report a significantly altered cytokine profile in FXS. The characterization of an immunological profile in FXS with and without autism may help to elucidate if an abnormal immune response may play a role and help to identify mechanisms important in the etiology of autism both with and without FXS.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Distribution of IL-1α, IL-6, RANTES and IP-10 among FXS, FXS+AU and typically developing controls (IL-1α: FXS+AU vs. control p = 0.003, FXS vs. control p = 0.009; IL-6: FXS+AU vs. FXS p = 0.007; RANTES: FXS vs. control p < 0.001; IP-10: FXS+AU vs. control p < 0.001; FXS vs. control p < 0.001). y-axis represents cytokine levels in log scale (Log (pg/ml)). Horizontal box lines are 25%, 50% (median) and 75% of the distribution with whiskers marking 1.5 times the interquartile range. Open circles indicate potential outliers. Analysis results with or without these two data points did not differ.

References

    1. Ashwood P, Anthony A, Pellicer AA, Torrente F, Walker-Smith JA, Wakefield AJ. Intestinal lymphocyte populations in children with regressive autism: evidence for extensive mucosal immunopathology. J Clin Immunol. 2003;23:504–517. - PubMed
    1. Ashwood P, Anthony A, Torrente F, Wakefield AJ. Spontaneous mucosal lymphocyte cytokine profiles in children with autism and gastrointestinal symptoms: mucosal immune activation and reduced counter regulatory interleukin-10. J Clin Immunol. 2004;24:664–673. - PubMed
    1. Ashwood P, W S, Van de Water J. The immune response in autism: a new frontier for autism research. J Leukoc Biol. 2006;80:1–15. - PubMed
    1. Cabanlit M, W S, Goines P, Ashwood P, Van de Water J. Brain-specific Autoantibodies in the Plasma of Subjects with Autistic Spectrum Disorder. Ann NY Acad Sci. 2007:92–103. - PubMed
    1. Coffey SM, C K, Tartaglia N, Tassone F, Nguyen DV, Pan R, Bronsky HE, Yuhas J, Borodyanskaya M, Grigsby J, Doerflinger M, Hagerman PJ, Hagerman RJ. Expanded clinical phenotype of women with the FMR1 premutation. Am J Med Genet A. 2008;146A:1009–1016. - PMC - PubMed

Publication types

MeSH terms